# Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

> **NCT00608075** · PHASE4 · UNKNOWN · sponsor: **University of Cincinnati** · enrollment: 260 (estimated)

## Conditions studied

- Bipolar I Disorder

## Interventions

- **DRUG:** lithium
- **DRUG:** Lithium

## Key facts

- **NCT ID:** NCT00608075
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2015-07
- **Final completion:** 2017-07
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2016-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00608075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00608075, "Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00608075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*